Sponsored by:

Molecular Imaging: Page 325

Int'l Isotopes grows revenue in Q2
By AuntMinnie.com staff writers
Revenue gains in all business segments in the first six months of 2011 propelled radioisotope manufacturer International Isotopes to double-digit growth in the first half of this year.
August 11, 2011
FDA releases PET drug guidelines
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has issued its final guidance on current good manufacturing practices for PET radiopharmaceuticals.
August 11, 2011
Neoprobe submits NDA for Lymphoseek
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has submitted a new drug application (NDA) with the U.S. Food and Drug Administration for its Lymphoseek radiopharmaceutical for determining whether cancer has spread to the lymph nodes.
August 10, 2011
NARSAD grants awarded to 15 projects
By AuntMinnie.com staff writers
The Brain & Behavior Research Foundation has awarded $1.5 million in National Alliance for Research on Schizophrenia and Depression (NARSAD) Distinguished Investigator grants to 15 recipients for research on brain and behavior disorders.
August 9, 2011
NIA debuts radiation calculator
By AuntMinnie.com staff writers
Radiology benefits management firm National Imaging Associates (NIA) has launched a radiation calculator available on the Internet and as an app for the iPhone, iPod touch, and iPad.
August 9, 2011
VC cost-effectiveness; PET for Hodgkin's lymphoma, cardiac ischemia
By Brian Casey
August 8, 2011
PET with rubidium-82 predicts cardiac events
By Wayne Forrest
Canadian researchers have found that PET scans with the radiopharmaceutical rubidium-82 can predict major adverse cardiac events independent of other parameters, according to results published online August 9 in the Journal of the American College of Cardiology.
August 8, 2011
FDG-PET finds bone marrow involvement in Hodgkin's lymphoma
By Wayne Forrest
FDG-PET is sensitive and specific in detecting bone marrow involvement in pediatric Hodgkin's lymphoma patients and may be a safe alternative to an invasive bone marrow biopsy in routine staging procedures, according to a study published online August 8 in the Journal of Clinical Oncology.
August 8, 2011
Despite false positives, PET/CT can help manage HIV patients
By Wayne Forrest
Despite an abundance of false-positive results, FDG-PET/CT can provide "valuable insight" into the progression of disease in HIV patients without the need for biopsy, according to a paper in the August issue of the American Journal of Roentgenology.
August 7, 2011
2011 08 05 14 30 35 832 Fdg Pet Ct Hiv Images Ajr Thumb
SPECT tracer could cut staging costs for NSCLC
By Tami Freeman
There may be an alternative to non-small cell lung cancer (NSCLC) diagnosis and staging using FDG-PET: low-cost SPECT imaging with a new molecular imaging agent, according to research from MD Anderson Cancer Center and biopharmaceutical company Cell>Point.
August 5, 2011
2011 08 05 10 31 37 792 Spect Nsclc Md Anderson Thumb
Siemens' Biograph wins Canadian approval
By AuntMinnie.com staff writers
Siemens Healthcare said its Biograph mMR hybrid PET/MRI scanner has received a Health Canada medical device license.
August 3, 2011
Shimadzu inks R&D deal with Japanese institute
By AuntMinnie.com staff writers
Shimadzu has signed a research and development agreement with Japan's National Cancer Center that aims to identify early-stage biomarker candidates and develop them into molecular imaging products capable of providing early diagnosis of cancer.
August 3, 2011
Previous Page
Page 325 of 612
Next Page